Atlas Trials

Extension Study of MT-1303 in Subjects With Crohn's Disease

Clinical trial NCT02389790 · COMPLETED

Trial details

NCT number
NCT02389790
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2015-08-01
Primary completion
2017-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.